Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-101 Solution in Common Warts
NCT02669862Phase 2Completed
- Sponsor
- Aclaris Therapeutics, Inc.
- Start
- Dec 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrogen peroxide in common warts, sponsored by Aclaris Therapeutics, Inc.. Started Dec 2015; status: completed.
02
Drugs
hydrogen peroxide
03
Conditions
common warts
Beyond the preview
Go deeper on NCT02669862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02669862.